The tests, revealed at the 2021 American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Lab Expo in Atlanta, could improve screening rates for colorectal and prostate cancers, since studies show many patients avoid colonoscopies and prostate exams because they’re invasive.
The blood test for colorectal cancer is more accurate than routine stool occult blood tests, researchers said.
The saliva test distinguishes between prostate cancer and benign prostate enlargement by testing for eight different microRNAs that either support or suppress tumor growth.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
